Skip to main content
Log in

LncRNA HCG18 promotes inflammation and apoptosis in intervertebral disc degeneration via the miR-495-3p/FSTL1 axis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Intervertebral disc degeneration (IDD) causes pain in the back and neck. This study investigated the role of long non-coding RNA HLA complex group 18 (HCG18) in a cell model of IDD. An IDD model was established by stimulating nucleus pulposus (NP) cells with interleukin (IL)-1β. MTT assay was performed to evaluate NP cell viability. The apoptosis was detected by flow cytometry. The expressions of HCG18, microRNA (miR)-495-3p, and follistatin-like protein-1 (FSTL1) were measured by RT-qPCR. The interactions of miR-495-3p with HCG18 and FSTL1 were analyzed by luciferase reporter assay. IL-1β stimulation upregulated HCG18 and FSTL1, but downregulated miR-495-3p in NP cells. Silencing of HCG18 or FSTL1, as well as miR-495-3p overexpression in NP cells alleviated IL-1β-induced apoptosis and inflammation of NP cells. Both HCG18 and FSTL1 had binding sites for miR-495-3p. Overexpression of FSTL1 abolished the effects of HCG18 silencing on IL-1β-induced apoptosis and inflammation. The HCG18/miR-495-3p/FSTL1 axis is essential for IDD development. Therapeutic strategies targeting this axis may be used for IDD treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article.

References

  1. Buchbinder R, Blyth FM, March LM, Brooks P, Woolf AD, Hoy DG (2013) Placing the global burden of low back pain in context. Best Pract Res Clin Rheumatol 27:575–589. https://doi.org/10.1016/j.berh.2013.10.007

    Article  PubMed  Google Scholar 

  2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA and Memish ZA (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–96. https://doi.org/10.1016/S0140-6736(12)61729-2

  3. Freemont AJ (2009) The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 48:5–10. https://doi.org/10.1093/rheumatology/ken396

    Article  CAS  PubMed  Google Scholar 

  4. Mirza SK and Deyo RA (2007) Systematic review of randomized trials comparing lumbar fusion surgery to nonoperative care for treatment of chronic back pain. Spine (Phila Pa 1976) 32:816–823. https://doi.org/10.1097/01.brs.0000259225.37454.38

  5. Hoyland JA, Le Maitre C, Freemont AJ (2008) Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) 47:809–814. https://doi.org/10.1093/rheumatology/ken056

    Article  CAS  PubMed  Google Scholar 

  6. Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7:R732–R745. https://doi.org/10.1186/ar1732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ungar B, Levy I, Yavne Y, Yavzori M, Picard O, Fudim E, Loebstein R, Chowers Y, Eliakim R, Kopylov U and Ben-Horin S (2016) Optimizing anti-TNF-alpha therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 14:550–557 e2. https://doi.org/10.1016/j.cgh.2015.10.025

  8. Gronblad M, Virri J, Tolonen J, Seitsalo S, Kaapa E, Kankare J, Myllynen P and Karaharju EO (1994) A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine (Phila Pa 1976) 19:2744–2751. https://doi.org/10.1097/00007632-199412150-00002

  9. Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N (2007) Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann N Y Acad Sci 1096:44–54. https://doi.org/10.1196/annals.1397.069

    Article  CAS  PubMed  Google Scholar 

  10. Salama AD, Little MA (2015) The Janus Faces of IL-6 in GN. J Am Soc Nephrol 26:1480–1482. https://doi.org/10.1681/ASN.2014111141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liang H, Yang X, Liu C, Sun Z, Wang X (2018) Effect of NF-kB signaling pathway on the expression of MIF, TNF-alpha, IL-6 in the regulation of intervertebral disc degeneration. J Musculoskelet Neuronal Interact 18:551–556

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159. https://doi.org/10.1038/nrg2521

    Article  CAS  PubMed  Google Scholar 

  13. Batista PJ, Chang HY (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell 152:1298–1307. https://doi.org/10.1016/j.cell.2013.02.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yang L, Froberg JE, Lee JT (2014) Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci 39:35–43. https://doi.org/10.1016/j.tibs.2013.10.002

    Article  CAS  PubMed  Google Scholar 

  15. Xi Y, Jiang T, Wang W, Yu J, Wang Y, Wu X, He Y (2017) Long non-coding HCG18 promotes intervertebral disc degeneration by sponging miR-146a-5p and regulating TRAF6 expression. Sci Rep 7:13234. https://doi.org/10.1038/s41598-017-13364-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li Z, Li X, Chen C, Li S, Shen J, Tse G, Chan MTV and Wu WKK (2018) Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif 51:e12483. https://doi.org/10.1111/cpr.12483

  17. Wang J, Haubrock M, Cao KM, Hua X, Zhang CY, Wingender E, Li J (2011) Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol 5:199. https://doi.org/10.1186/1752-0509-5-199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lin X, Lin Q (2020) MiRNA-495-3p attenuates TNF-alpha induced apoptosis and inflammation in human nucleus pulposus cells by targeting IL5RA. Inflammation 43:1797–1805. https://doi.org/10.1007/s10753-020-01254-5

    Article  CAS  PubMed  Google Scholar 

  19. Shibanuma M, Mashimo J, Mita A, Kuroki T, Nose K (1993) Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem 217:13–19. https://doi.org/10.1111/j.1432-1033.1993.tb18212.x

    Article  CAS  PubMed  Google Scholar 

  20. Kawabata D, Tanaka M, Fujii T, Umehara H, Fujita Y, Yoshifuji H, Mimori T, Ozaki S (2004) Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum 50:660–668. https://doi.org/10.1002/art.20023

    Article  CAS  PubMed  Google Scholar 

  21. Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, Hirsch R (2010) Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 62:2510–2516. https://doi.org/10.1002/art.27485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ogura Y, Ouchi N, Ohashi K, Shibata R, Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, Enomoto T, Uemura Y, Miyabe M, Ishii M, Yamamoto T, Shimizu Y, Walsh K, Murohara T (2012) Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation 126:1728–1738. https://doi.org/10.1161/CIRCULATIONAHA.112.115089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Torres S, Bartolome RA, Mendes M, Barderas R, Fernandez-Acenero MJ, Pelaez-Garcia A, Pena C, Lopez-Lucendo M, Villar-Vazquez R, de Herreros AG, Bonilla F, Casal JI (2013) Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 19:6006–6019. https://doi.org/10.1158/1078-0432.CCR-13-1130

    Article  CAS  PubMed  Google Scholar 

  24. Clutter SD, Wilson DC, Marinov AD, Hirsch R (2009) Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol 182:234–239. https://doi.org/10.4049/jimmunol.182.1.234

    Article  CAS  PubMed  Google Scholar 

  25. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, Robbins P, Hirsch R (2006) Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol 177:4758–4762. https://doi.org/10.4049/jimmunol.177.7.4758

    Article  CAS  PubMed  Google Scholar 

  26. Fan N, Sun H, Wang Y, Wang Y, Zhang L, Xia Z, Peng L, Hou Y, Shen W, Liu R, Yin J and Peng Y (2013) Follistatin-like 1: a potential mediator of inflammation in obesity. Mediators Inflamm 2013:752519. https://doi.org/10.1155/2013/752519

  27. Peng P, Wang D, Xu X, Wang D, Gao B, Wang H, Jia H, Shang Q, Zheng C, Gao C, Mao J, Luo Z, Yang L, Hu X (2022) Targeting clock-controlled gene Nrf2 ameliorates inflammation-induced intervertebral disc degeneration. Arthritis Res Ther 24:181. https://doi.org/10.1186/s13075-022-02876-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jin H, Wang Q, Wu J, Han X, Qian T, Zhang Z, Wang J, Pan X, Wu A, Wang X (2019) Baicalein inhibits the IL-1beta-induced inflammatory response in nucleus pulposus cells and attenuates disc degeneration in vivo. Inflammation 42:1032–1044. https://doi.org/10.1007/s10753-019-00965-8

    Article  CAS  PubMed  Google Scholar 

  29. Huang Y, Jiang T, Chen J, Yin GY, Fan J (2018) Effects of kartogenin on the attenuated nucleus pulposus cell degeneration of intervertebral discs induced by interleukin-1beta and tumor necrosis factor alpha. Int J Mol Med 41:749–756. https://doi.org/10.3892/ijmm.2017.3283

    Article  CAS  PubMed  Google Scholar 

  30. Zhu H, Chen G, Wang Y, Lin X, Zhou J, Wang Z, Suo N (2020) Dimethyl fumarate protects nucleus pulposus cells from inflammation and oxidative stress and delays the intervertebral disc degeneration. Exp Ther Med 20:269. https://doi.org/10.3892/etm.2020.9399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Su X, Liu B, Gong F, Yin J, Sun Q, Gao Y, Lv Z, Wang X (2019) Isofraxidin attenuates IL-1beta-induced inflammatory response in human nucleus pulposus cells. J Cell Biochem 120:13302–13309. https://doi.org/10.1002/jcb.28604

    Article  CAS  PubMed  Google Scholar 

  32. Wang K, Chen T, Ying X, Zhang Z, Shao Z, Lin J, Xu T, Chen Y, Wang X, Chen J, Sheng S (2019) Ligustilide alleviated IL-1beta induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo. Int Immunopharmacol 69:398–407. https://doi.org/10.1016/j.intimp.2019.01.004

    Article  CAS  PubMed  Google Scholar 

  33. Wang X, Wang B, Zou M, Li J, Lu G, Zhang Q, Liu F, Lu C (2018) CircSEMA4B targets miR-431 modulating IL-1beta-induced degradative changes in nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway. Biochim Biophys Acta Mol Basis Dis 1864:3754–3768. https://doi.org/10.1016/j.bbadis.2018.08.033

    Article  CAS  PubMed  Google Scholar 

  34. Yu L, Hao Y, Xu C, Zhu G, Cai Y (2019) LINC00969 promotes the degeneration of intervertebral disk by sponging miR-335-3p and regulating NLRP3 inflammasome activation. IUBMB Life 71:611–618. https://doi.org/10.1002/iub.1989

    Article  CAS  PubMed  Google Scholar 

  35. Cheng X, Zhang L, Zhang K, Zhang G, Hu Y, Sun X, Zhao C, Li H, Li YM, Zhao J (2018) Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein. Ann Rheum Dis 77:770–779. https://doi.org/10.1136/annrheumdis-2017-212056

    Article  CAS  PubMed  Google Scholar 

  36. Zhen L, Jiang X, Chen Y, Fan D (2017) MiR-31 is involved in the high glucose-suppressed osteogenic differentiation of human periodontal ligament stem cells by targeting Satb2. Am J Transl Res 9:2384–2393

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Eun JW, Kim HS, Shen Q, Yang HD, Kim SY, Yoon JH, Park WS, Lee JY, Nam SW (2018) MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis. J Pathol 244:107–119. https://doi.org/10.1002/path.4994

    Article  CAS  PubMed  Google Scholar 

  38. Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, Zhao C, Li H, Li YM, Zhao J (2018) Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med 22:261–276. https://doi.org/10.1111/jcmm.13316

    Article  CAS  PubMed  Google Scholar 

  39. Shi J, Wang S, He Q, Liu K, Zhao W, Xie Q, Cheng L (2021) TNF-alpha induces up-regulation of MicroRNA-27a via the P38 signalling pathway, which inhibits intervertebral disc degeneration by targeting FSTL1. J Cell Mol Med. https://doi.org/10.1111/jcmm.16745

    Article  PubMed  PubMed Central  Google Scholar 

  40. Zhang W, Wang W, Liu J, Li J, Wang J, Zhang Y, Zhang Z, Liu Y, Jin Y, Li J, Cao J, Wang C, Ning W, Wang J (2017) Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice. Sci Rep 7:45820. https://doi.org/10.1038/srep45820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to give our sincere gratitude to the reviewers for their constructive comments.

Funding

This work was supported by Scientific research project of Health Commission of Hunan Province (No.202204072873).

Author information

Authors and Affiliations

Authors

Contributions

Yi Luo wrote the main manuscript text and Yi Luo, Youzhi He, Yongfu Wang, Yuxia Xu and Li Yang prepared figures. All authors reviewed the manuscript.

Corresponding author

Correspondence to Yi Luo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Y., He, Y., Wang, Y. et al. LncRNA HCG18 promotes inflammation and apoptosis in intervertebral disc degeneration via the miR-495-3p/FSTL1 axis. Mol Cell Biochem 479, 171–181 (2024). https://doi.org/10.1007/s11010-023-04716-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-023-04716-0

Keywords

Navigation